| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0007 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |